U.S., Oct. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07903311) titled 'Iron Repletion in Cystic Fibrosis' on Oct. 21.
Brief Summary: The researchers in this study hope to learn whether oral (PO) or intravenous (IV) iron treatments are better for treating iron deficiency in patients with cystic fibrosis (CF). This research will help doctors better treat iron deficiency in patients with CF in the future by examining blood and other health measures.
Study Start Date: Nov., 2026
Study Type: INTERVENTIONAL
Condition:
Cystic Fibrosis
Iron Deficiencies
Iron Deficiency Diseases
Intervention:
DRUG: IV Repletion
Possible formulation and dose will depend on the participant's treating clinician, and may inc...